|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Current assets: | ||||||||||
| Cash | ||||||||||
| Cash and cash equivalents | ||||||||||
| Restricted cash | ||||||||||
| Trade, less allowance for credit losses of $1.1 and $1.1, respectively | ||||||||||
| Other | ||||||||||
| Accounts receivable, less allowance for credit losses of $2.1 and $1.1, respectively | ||||||||||
| Inventories | ||||||||||
| Derivative assets | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Property, plant and equipment, net | ||||||||||
| Goodwill | ||||||||||
| Other intangible assets, net | ||||||||||
| Operating lease right-of-use assets | ||||||||||
| Other noncurrent assets, net | ||||||||||
| Total assets | ||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued interest payable | ||||||||||
| Accrued salaries, wages and benefits | ||||||||||
| Other taxes payable | ||||||||||
| Obligations under inventory financing agreements | ||||||||||
| Current portion of RINs obligation | ||||||||||
| Current portion of operating lease liabilities | ||||||||||
| Derivative liabilities | ||||||||||
| Other current liabilities | ||||||||||
| Current portion of long-term debt | ||||||||||
| Total current liabilities | ||||||||||
| Pension and postretirement benefit obligations | ||||||||||
| Other long-term liabilities | ||||||||||
| Long-term operating lease liabilities | ||||||||||
| Long-term debt, less current portion | ||||||||||
| Total liabilities | ||||||||||
| Redeemable noncontrolling interest and other equity instruments | ||||||||||
| Stockholders' equity: | ||||||||||
| Common stock: par value $0.01 per share, 700,000,000 shares authorized, and 88,079,064 and 86,776,552 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively. | ||||||||||
| Additional paid-in capital | ||||||||||
| Warrants: 2,000,000 warrants issued and outstanding December 31, 2025 | ||||||||||
| Accumulated deficit | ||||||||||
| Partners' interest | ||||||||||
| Limited Partners | ||||||||||
| General Partner | ||||||||||
| Accumulated other comprehensive loss | ||||||||||
| Total stockholders' equity | ||||||||||
| Total liabilities and stockholders' equity |
Loading...